106 International, multicenter, randomized, controlled study for the treatment of patients with chronic hepatitis C and persistently normal ALT levels with peginterferon alfa-2A (40KD) (PEGASYS®) and ribavirin (copegus®)
Stefan Zeuzem, Moisés Diago, Edward Gane, Rajender Reddy, Paul Pockros, Patrizia Farci, Norman Lardelli, Mitchell ShiffmanVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0270-9139(03)80149-0
File:
PDF, 143 KB
english, 2003